CTLA4 and neoplasm: However, by combining LIGHT-VTP with checkpoint blockade of both CTLA-4 and PD-1 (termed ‘LIGHT-VTP triple therapy’) there was an inhibition of tumour growth, necrotic haemorrhaging and prolonged survival [46 ].